Evoke Pharma Inc. (EVOK)
NASDAQ: EVOK
· Real-Time Price · USD
5.08
-0.06 (-1.17%)
At close: Aug 15, 2025, 3:59 PM
5.00
-1.48%
After-hours: Aug 15, 2025, 07:53 PM EDT
Evoke Pharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 11.59M | 10.25M | 8.62M | 7.53M | 6.11M | 5.18M | 4.3M | 3.57M | 2.9M | 2.51M | 2.07M | 2.17M | 1.95M | 1.62M | 1.28M | 350.08K | 113.44K |
Cost of Revenue | 305.62K | 356.53K | 297.06K | 227.94K | 243.82K | 201.88K | 332.94K | 387.81K | 398.22K | 370.39K | 316.99K | 285.65K | 286.13K | 328.12K | 278.15K | 219.72K | 151.46K |
Gross Profit | 11.29M | 9.89M | 8.32M | 7.3M | 5.86M | 4.98M | 3.97M | 3.18M | 2.5M | 2.14M | 1.76M | 1.89M | 1.66M | 1.29M | 1M | 130.36K | -38.02K |
Operating Income | -5M | -5.2M | -5.9M | -6.22M | -6.78M | -7.43M | -7.25M | -7.56M | -7.89M | -7.79M | -7.62M | -7.56M | -7.61M | -8.15M | -8.81M | -9.05M | -13.84M |
Interest Income | 426.11K | 353.31K | 252.9K | 189.16K | 149.32K | 138.6K | 144.64K | 133.8K | 96.54K | 62.01K | 30.44K | 7.14K | 6.25K | 8.62K | 8.37K | 7.98K | 5.46K |
Pretax Income | -5.08M | -5.35M | -6.15M | -6.53M | -7.13M | -7.79M | -7.61M | -7.93M | -8.29M | -8.22M | -8.09M | -8.05M | -8.11M | -8.54M | -9.13M | -9.29M | -13.97M |
Net Income | -5.08M | -5.35M | -6.15M | -6.53M | -7.13M | -8M | -7.79M | -8.11M | -8.47M | -8.19M | -8.09M | -8.04M | -8.11M | -8.54M | -9.13M | -9.29M | -13.97M |
Selling & General & Admin | 16.24M | 15.08M | 14.18M | 13.49M | 12.52M | 12.23M | 11.03M | 10.52M | 10.07M | 9.62M | 9.07M | 9.09M | 8.92M | 8.85M | 9.16M | 8.4M | 7.44M |
Research & Development | 54.46K | 16.32K | 38.88K | 27.2K | 119.56K | 181.91K | 186.55K | 226.94K | 326.06K | 300.79K | 309.31K | 350.62K | 354.37K | 590.48K | 658.6K | 781.93K | 6.37M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 22.76K | 22.76K | 22.76K | 22.76K | n/a | n/a | n/a | n/a |
Operating Expenses | 16.29M | 15.1M | 14.22M | 13.51M | 12.64M | 12.41M | 11.22M | 10.74M | 10.39M | 9.92M | 9.38M | 9.44M | 9.27M | 9.44M | 9.82M | 9.18M | 13.81M |
Interest Expense | 500K | 501.37K | 501.37K | 501.37K | 501.37K | 500K | 500K | 500K | 500K | 500K | 500K | 500K | 500K | 500.05K | 433.58K | 358.08K | 236.33K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.35M | -2.35M | -2.35M |
Cost & Expenses | 16.6M | 15.45M | 14.52M | 13.74M | 12.88M | 12.61M | 11.55M | 11.13M | 10.79M | 10.29M | 9.7M | 9.73M | 9.56M | 9.77M | 10.09M | 9.4M | 13.96M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | 211.25K | 178.66K | 178.66K | 174.75K | -37.29K | -5.72K | -5.72K | -1.81K | -1.02K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 2.55M | 1.49M | 1.4M | 1.36M | 756.81K | 278.59K | 278.59K | 278.59K | 278.59K | 278.59K | 278.59K | 263.08K | 227.62K | 226.78K | 225.99K | 224.9K | 216.38K |
Shares Outstanding (Diluted) | 2.55M | 1.49M | 1.4M | 1.36M | 756.81K | 278.59K | 278.59K | 278.59K | 278.59K | 278.59K | 278.59K | 263.08K | 227.62K | 226.78K | 225.99K | 224.9K | 216.38K |
EPS (Basic) | -3.18 | -4.76 | -11.09 | -16.23 | -22 | -28.72 | -27.95 | -29.1 | -30.87 | -31.61 | -32.62 | -34.1 | -35.82 | -38.31 | -43.21 | -46.23 | -76.19 |
EPS (Diluted) | -3.18 | -4.76 | -11.09 | -16.23 | -22 | -28.72 | -27.95 | -29.1 | -30.87 | -31.61 | -32.62 | -34.1 | -35.82 | -38.31 | -43.21 | -46.23 | -76.19 |
EBITDA | -4.58M | -4.85M | -5.65M | -6.03M | -6.63M | -7.29M | -7.11M | -7.43M | -7.79M | -7.72M | -7.59M | -7.55M | -7.61M | -8.04M | -8.7M | -8.94M | -13.73M |
EBIT | -4.58M | -4.85M | -5.65M | -6.03M | -6.63M | -7.29M | -7.11M | -7.43M | -7.79M | -7.72M | -7.59M | -7.55M | -7.61M | -8.04M | -8.7M | -8.94M | -13.73M |
Depreciation & Amortization | n/a | n/a | 1.89M | 3.49M | 5.28M | 7.43M | 7.25M | 7.56M | 7.89M | 7.79M | 7.62M | 7.56M | 7.61M | 8.15M | 8.81M | 9.05M | 13.84M |